Eradication of poliomyelitis: When can one be sure that polio virus transmission has been terminated?

American Journal of Epidemiology

Volumn 143, Issue 8, 1996, Pages 816-822

  Eichner, M ^a,b   Dietz, K ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

computer simulation; mathematical computing; models, theoretical; poliomyelitis; poliovirus vaccine; poliovirus vaccine, oral

Indexed keywords

INACTIVATED VIRUS VACCINE; ORAL POLIOMYELITIS VACCINE;

ARTICLE; COMPUTER SIMULATION; HUMAN; MAJOR CLINICAL STUDY; POLIOMYELITIS; POLIOMYELITIS VIRUS; PROBABILITY; STOCHASTIC MODEL; VACCINATION; VIRUS TRANSMISSION;

EID: 0029988559     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008820     Document Type: Article

References (18)

1. Fenner F, Henderson DA, Arita I, et al, eds. Smallpox and its eradication. Geneva: World Health Organization, 1988.
2. Gillespie DT. A general method for numerically simulating the stochastic time evolution of coupled chemical reactions. J Comput Phys 1976;22:403-34.
3. Gear JHS, Measroch V. Poliomyelitis in Southern Africa: In: Poliomyelitis: papers and discussions presented at the Second International Poliomyelitis Conference, 1952:437-41.
4. Gelfand HM, Miller MJ. Poliomyelitis in Liberia. Prevalence of the disease, sero-immunity resulting from subclinical infection, and indications for prophylactic vaccination. Am J Trop Med Hyg 1956;5:791-6.
5. Paul JR, Melnick JL, Barnett VH, et al. A survey of neutralizing antibodies to poliomyelitis virus in Cairo, Egypt. Am J Hyg 1952;55:402-13.
6. Dietz K. The estimation of the basic reproduction number for infectious diseases. Stat Methods Med Res 1993;2:23-41.
7. Gelfand HM, LeBlanc DR, Fox JP, et al. Studies on the development of natural immunity to poliomyelitis in Louisiana. II. Description and analysis of episodes of infection observed in study group households. Am J Hyg 1957;65: 367-85.
8. Marine WM, Chin TDY, Gravelle CR. Limitation of fecal and pharyngeal poliovirus excretion in Salk-vaccinated children: a family study during a type 1 poliomyelitis epidemic. Am J Hyg 1962;76:173-95.
9. Ghendon YZ, Sanakoyeva II. Comparison of the resistance of the intestinal tract to poliomyelitis virus (Sabins strains) in persons after naturally and experimentally acquired immunity. Acta Virol (Praha) 1961;5:265-73.
10. Henry JL, Jaikaran ES, Davies JR, et al. A study of poliovaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine, J Hyg 1966;64:105-20.
11. Ogra PL, Karzon DT. Formation and function of poliovirus antibody in different tissues. Prog Med Virol 1971;13: 156-93.
12. Lepow ML, Warren RJ, Gray N, et al. Effect of Sabin type 1 poliomyelitis vaccine administered by mouth to newborn infants. N Engl J Med 1961;264:1071-8.
13. Henderson RH. The World Health Organization's plan of action for global eradication of poliomyelitis by the year 2000. Ann NY Acad Sci 1989;569:69-85.
14. Fox JP, Gelfand HM, LeBlanc DR, et al. Studies on the development of natural immunity to poliomyelitis in Louisiana. I. Over-all plan, methods and observations as to patterns of seroimmunity in the study group. Am J Hyg 1957;65: 344-66.
15. Horstmann DM. Poliomyelitis: severity and type of disease in different age groups. Ann NY Acad Sci 1955;61:956-67.
16. Dietz K. Transmission and control of arbovirus diseases. In: Ludwig D, Cooke KL, eds. Epidemiology. Philadelphia: Society for Industrial and Applied Mathematics, 1975:104-21.
17. Hethcote HW. Asymptotic behavior and stability in epidemic models. Lecture Notes Biomath 1974;2:83-92.
18. Eichner M, Hadeler KP. Deterministic models for the eradication of poliomyelitis: vaccination with the inactivated (IPV) and attenuated (OPV) polio virus vaccine. Math Biosci 1995; 127:149-66.